Torrent Pharmaceuticals Limited engages in the manufacture and sale of branded and unbranded generic pharmaceutical products principally in India. It principally focuses on cardiovascular, gastrointestinal, central nervous system, anti-infective, pain management, and anti-diabetics areas. Torrent Pharmaceuticals offers tablets, capsules, and parenterals. The company’s products include Nicorandil, Risperidone, Venlafaxine Hydrochloride, Ropinarole Hydrochloride, Duloxetine Hydrochloride, Ormeloxifen Hydrochloride, Nebivolol Hydrochloride, Lamotrigine, Sertraline Hydrochloride, and Clopidogrel bisulphate. It has a collaboration agreement with AstraZeneca AB for discovering a drug candidate for the treatment of hypertension. Torrent Pharmaceuticals also operates primarily in the United States, Latin America, Russia, Commonwealth of Independent States, Europe, and Japan. The company was founded in 1959. It was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. Torrent Pharmaceuticals is based in Ahmedabad, India.